← Eichor
Study identifier: NCT07706452 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dual-Task Balance Training in Traumatic Lower-Limb Prosthesis Users

Condition: Lower Limb Amputation · Prosthesis Users · Balance Impairment  ·  Sponsor: Al-Azhar University - Gaza

PhaseNA
Planned participants63
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized controlled trial will evaluate the effectiveness of dual-task balance training on balance, mobility, and mental health among traumatic lower-limb prosthesis users in the Gaza Strip. Participants will be randomly assigned to either an experimental group receiving dual-task balance training in addition to standard rehabilitation or a control group receiving standard rehabilitation only. The intervention will be delivered over 6 weeks, with three sessions per week. Balance and mobility will be assessed using the Berg Balance Scale and the Amputee Mobility Predictor with Prosthesis, while mental health will be assessed using the Depression, Anxiety, and Stress Scale-21.

This description comes directly from the study's public registry record.

Talk to the study team

Rawan Nabil Alessi, MSc Student / BSc PT  ·  +972597288395  ·  Rawan.n.elessi@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Artificial Limb and Polio CentreGaza, Gaza Strip, Palestinian TerritoriesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07706452